On 2025-05-14, Bionano Genomics, Inc. (BNGO) announced earnings per share of $-1.15 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-3.49.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-2.69 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-3.49 | $-1.15 |
| 2024-11-14 | 2024-09-30 | -- | $-19.16 |
| 2024-08-07 | 2024-06-30 | -- | $-14.37 |
| 2024-05-08 | 2024-03-31 | -- | $-35.93 |
| 2024-03-05 | 2023-12-31 | -- | $-57.49 |
| 2023-11-08 | 2023-09-30 | $-44.91 | $-88.62 |
| 2023-08-09 | 2023-06-30 | $-53.89 | $-74.25 |
| 2023-05-09 | 2023-03-31 | $-53.89 | $-71.86 |
| 2023-03-09 | 2022-12-31 | $-53.89 | $-77.84 |
| 2022-11-03 | 2022-09-30 | $-71.86 | $-65.87 |
| 2022-08-04 | 2022-06-30 | $-59.88 | $-65.87 |
| 2022-05-05 | 2022-03-31 | $-47.90 | $-65.87 |
| 2022-03-01 | 2021-12-31 | $-41.92 | $-47.90 |
| 2021-11-04 | 2021-09-30 | $-35.93 | $-41.92 |
| 2021-08-04 | 2021-06-30 | $-29.94 | $-35.93 |
| 2021-05-13 | 2021-03-31 | $-29.94 | $-29.94 |
| 2021-03-23 | 2020-12-31 | $-35.93 | $-35.93 |
| 2020-11-13 | 2020-09-30 | $-35.93 | $-47.90 |
| 2020-08-13 | 2020-06-30 | $-53.89 | $-53.89 |
| 2020-06-18 | 2020-03-31 | $-131.74 | $-179.64 |
| 2019-11-07 | 2019-09-30 | $-341.32 | $-353.29 |
| 2019-08-08 | 2019-06-30 | $-341.32 | $-425.15 |
| 2019-05-09 | 2019-03-31 | $-335.33 | $-407.19 |
| 2019-03-14 | 2018-12-31 | $-287.43 | $-371.26 |
| 2018-11-07 | 2018-09-30 | $-329.34 | $-377.25 |